D
Enliven Therapeutics, Inc. ELVN
$20.32 $0.3751.88% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 22.78% 12.98% 75.14% 73.85% 58.23%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 16.18% 21.96% 25.51% 17.95% 30.63%
Operating Income -16.18% -21.96% -25.51% -17.95% -30.63%
Income Before Tax -28.49% -25.53% -19.67% -11.49% -17.92%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -26.99% -25.53% -19.67% -11.49% -19.31%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -26.99% -25.53% -19.67% -11.49% -19.31%
EBIT -16.18% -21.96% -25.51% -17.95% -30.63%
EBITDA -16.22% -22.04% -25.60% -18.01% -30.73%
EPS Basic -17.16% -5.45% 1.30% 5.24% -1.67%
Normalized Basic EPS -13.95% -5.44% -9.80% -1.08% -13.34%
EPS Diluted -17.16% -5.45% 1.30% 5.24% -1.67%
Normalized Diluted EPS -13.95% -5.44% -9.80% -1.08% -13.34%
Average Basic Shares Outstanding 8.38% 19.04% 21.23% 17.64% 17.37%
Average Diluted Shares Outstanding 8.38% 19.04% 21.23% 17.64% 17.37%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --